Peripheral neuropathy in colorectal cancer survivors: The influence of oxaliplatin administration. Results from the population-based PROFILES registry

Keywords

Medicine, Oxaliplatin, Cumulative dose, Chemotherapy-induced peripheral neuropathy, Colorectal cancer

References

• Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.恭子 西内, 友香 富田, 理佳 宮崎 — 2001
• Gain of function NaV1.7 mutations in idiopathic small fiber neuropathyNel Diago — 2012
• Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter studyLuiz Paulo Grinberg — 2013
• Clinical pattern and associations of oxaliplatin acute neurotoxicityAndreas A. Argyriou, Guido Cavaletti, Chiara Briani — 2013
• The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons.Helmuth Adelsberger, Stefan Quasthoff, Julian Großkreutz — 2000
• Dose Effects of Oxaliplatin on Persistent and Transient Na+ Conductances and the Development of NeurotoxicitySusanna B. Park, Cindy Lin, Arun V. Krishnan — 2011
• Gain-of-function Nav1.8 mutations in painful neuropathyCatharina G. Faber, Giuseppe Lauria, Ingemar S.J. Merkies — 2012
• The NaV1.7 sodium channel: from molecule to manSulayman D. Dib‐Hajj, Yang Yang, Joel A. Black — 2012
• Mechanism of calcium entry during axon injury and degeneration.Richard M. LoPachin, Ellen J. Lehning — 1997
• Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.Hans‐Joachim Schmoll, Thomas H. Cartwright, Josep Tabernero — 2006
• The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.Tjeerd J. Postma, Neil K. Aaronson, Jan J. Heimans — 2005
• Safety and Efficacy of Modified FOLFOX6 for Treatment of Metastatic or Locally Advanced Colorectal CancerShigemi Matsumoto, Takafumi Nishimura, Masashi Kanai — 2008
• Capecitabine plus oxaliplatin (XELOX) versus 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) as first‐line treatment for metastatic colorectal cancerMichel Ducreux, Jaafar Bennouna, Mohamed Hebbar — 2011
• Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic reviewFloortje Mols, Tonneke Beijers, Gerard Vreugdenhil — 2014
• Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.Stephanie R. Land, Jacek A Kopec, Reena S. Cecchini — 2007
• Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients.Andreas A. Argyriou, Roser Velasco, Chiara Briani — 2012
• Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility.Susanna B. Park, Cindy Lin, Arun V. Krishnan — 2011
• Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.Floortje Mols, Tonneke Beijers, V.E.P.P. Lemmens — 2013
• Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.Thierry André, C. Boni, Matilde Navarro — 2009
• Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?D. Storey, Michelle D. Sakala, Catriona McLean — 2010

Cited by

• Assessment of acute oxaliplatin‐induced cold allodynia: a pilot studyLise Ventzel, C.S. Madsen, Anders Bonde Jensen — 2016
• Oleo gum resin of Ferula assa-foetida L. ameliorates peripheral neuropathy in mice.Farshad Homayouni Moghadam, Maryam Dehghan, Ehsan Zarepur — 2014
• Natural Products and Complementary Therapies for Chemotherapy-Induced Peripheral Neuropathy: A Systematic ReviewCloé Brami, Ting Bao, Gary Deng — 2015
• Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxelLise Ventzel, Anders Bonde Jensen, Anni Ravnsbæk Jensen — 2016
• Etude des canaux ioniques TREK 1 et HCN dans la neuropathie chimio-induite à l'oxaliplatine.L. Poupon — 2015
• Are chemotherapy-associated symptoms underestimated? A view beyond common toxicity criteriaAntoinetta J. M. Beijers, Floortje Mols, Corina J. van den Hurk — 2016
• Chemotherapy-induced peripheral neurotoxicity.Guido Cavaletti, P Marmiroli — 2015
• Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of lifeMåns Stefansson, Peter Nygren — 2016
• Laser Acupuncture Attenuates Oxaliplatin-Induced Peripheral Neuropathy in Patients with Gastrointestinal Cancer: A Pilot Prospective Cohort StudyYueh‐Ling Hsieh, Li‐Wei Chou, Shao-Fu Hong — 2016
• The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal StudyFelice N. van Erning, Maryska L.G. Janssen‐Heijnen, Johannes A. Wegdam — 2017
• Chemotherapy-Induced Neuropathy in Cancer SurvivorsChristine Miaskowski, Judy Mastick, Steven M. Paul — 2017
• Adjuvant Chemotherapy Among Elderly Colon Cancer Patients : from gut feeling towards evidence-based use in clinical practice : Adjuvante chemotherapie bij oudere patiënten met dikkedarmkanker : van onderbuikgevoel naar wetenschappelijk bewijs voor gebruik in de klinische praktijkF. Erning — 2016
• On a prolonged interval between rectal cancer (chemo)radiotherapy and surgeryBengt Glimelius — 2017
• Update on Chemotherapy-Induced Peripheral NeuropathyComana Cioroiu, Louis H. Weimer — 2017
• Need for adjuvant chemotherapy after colon cancer surgery – has it decreased?Camilla Böckelman, Bengt Glimelius — 2017
• Physical Activity, Bowel Function and Quality of Life among Rectal Cancer SurvivorsRobert S. Krouse, Christopher S. Wendel, David O. Garcia — 2017
• Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trialPhilipp Zimmer, Sina Trebing, Ursula Timmers-Trebing — 2018
• Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation.Rikke Heide, Hugh Bostock, Lise Ventzel — 2017
• Population-based cancer survivorship research: Experiences from Germany and the NetherlandsMelissa S. Y. Thong, Floortje Mols, Daniela Doege — 2018
• A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy.Eva Battaglini, Susanna B. Park, Elizabeth H Barnes — 2018

Related papers

• A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administrationAntoinetta J. M. Beijers, Floortje Mols, Gerard Vreugdenhil — 2014
• Clinical and Electrophysiological Studies of Chemotherapy-induced Peripheral NeuropathyShi Xiao — 2012
• Chemotherapy-induced peripheral neurotoxicity: single-centre prospective studyWala Ben Kridis, N. Toumi, Afef Khanfir — 2023
• Chemotherapy-Induced Peripheral Neuropathy in Egyptian Patients: Single Institution Retrospective AnalysisAhmed Gaballah, Amr Shafik, Khaled Elhusseiny — 2018
• Potential prevention and treatment of oxaliplatin associated peripheral neuropathy.Kristen Hoffman — 2004
• Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.J.C. MC HUGH, Dimitrios Tryfonopoulos, D. Fennelly — 2012
• High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experienceIwona Filipczak-Bryniarska, Roger M. Krzyżewski, Jakub Kucharz — 2017
• A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual DosePaola Alberti, Diego Cortinovis, Marina Elena Cazzaniga — 2012